MEP1B and cancer: Since the mutations D92H and D92Y cause an exchange of the preferred Asp92 to a disfavored amino acid within the meprin β cleavage site, we investigated whether shedding and cancer-associated cell behavior such as proliferation and migration would be altered and may contribute to tumor development and metastasis.